“So, what if only 10% of people with Alzheimer’s have genetics that predispose them to effective treatment with Anavex 2-73? If that were the case (I don’t see that it will be), the drug”
The AAIC poster seems will talk about bio-marker. Will they reveal the bio-marker they found and what were the results? Based on the biomarker - can someone guess what %age of population have those biomarkers?
falconer...thank you for the very thoughtful reply. I agree with all the points you make. And it might very well be that the future will point to a combination prevention and treatment program. That paradigm seems to be the direction of cancer treatments. I note that Anavex has at least one more drug that could potentially target Alzheimer's.
Market Data 
Markets 
AI
